Gunn & Company Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$740K Sell
835
-699
-46% -$628K 0.51% 41
2024
Q2
$1.39M Buy
1,534
+734
+92% +$587K 0.08% 61
2024
Q1
$622K Sell
800
-638
-44% -$454K 0.47% 43
2023
Q4
$838K Buy
1,438
+798
+125% +$466K 0.06% 55
2023
Q3
$344K Buy
+640
New +$330K 0.3% 48

Other funds holding LLY

Gunn & Company Investment Management's LLY Position: Q3 2024 in Review

Gunn & Company Investment Management reduced its Eli Lilly (LLY) stake by 46% in Q3 2024, selling an estimated $628K and leaving 835 shares worth $740K. The position accounts for 0.51% of the portfolio, ranked #41.

Gunn & Company Investment Management first reported a position in LLY in Q3 2023 and has held it in 5 quarters since. The position peaked at $1.39M in Q2 2024. 3,659 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • Gunn & Company Investment Management held 835 shares of Eli Lilly worth $740K as of Q3 2024.
  • Gunn & Company Investment Management sold 699 Eli Lilly shares in Q3 2024, an estimated $628K.
  • Eli Lilly made up 0.51% of Gunn & Company Investment Management's portfolio in Q3 2024, its #41 holding.
  • Gunn & Company Investment Management first reported a position in Eli Lilly in Q3 2023 and has held it in 5 quarters since.
  • Gunn & Company Investment Management's Eli Lilly position peaked at $1.39M in Q2 2024.
  • 3,659 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Gunn & Company Investment Management's 13F filing for Q3 2024, filed 22 Oct 2024.